FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Pushko

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Irina Tretyakova; Eryu Wang; Scott Weaver; Pamela Glass; Igor S Lukashevich; Peter Pushko
Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Peter Pushko; Thomas Kort; Margret Nathan; Melissa B Pearce; Gale Smith; Terrence M Tumpey
Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Pushko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Irina Tretyakova; Eryu Wang; Scott Weaver; Pamela Glass; Igor S Lukashevich; Peter Pushko
Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Vaccine 2013;31(7):1019-25.
2010: Peter Pushko; Thomas Kort; Margret Nathan; Melissa B Pearce; Gale Smith; Terrence M Tumpey
Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.
Vaccine 2010;28(30):4771-6.
2009: Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
Journal of virology 2009;83(11):5726-34.
2009: Sang-Moo Kang; Peter Pushko; Rick A Bright; Gale Smith; Richard W Compans
Influenza virus-like particles as pandemic vaccines.
Current topics in microbiology and immunology 2009;333():269-89.
2008: Rick A Bright; Donald M Carter; Corey J Crevar; Franklin Toapanta Yanchapaxi; Jonathan Steckbeck; Kelly S Cole; niranjan kumar; Peter Pushko; Gale Smith; Terrence M Tumpey; Ted M Ross
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
PloS one 2008;3(1):e1501.
2007: Bao-Zhong Wang; Weimin Liu; Sang-Moo Kang; Munir Alam; Chunzi Huang; Ling Ye; Yuliang Sun; Yingying Li; Denise L Kothe; Peter Pushko; Terje Dokland; Barton F Haynes; Gale Smith; Beatrice H Hahn; Richard W Compans
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
Journal of virology 2007;81(20):10869-78.
2007: Peter Pushko; Terrence M Tumpey; Neal Van Hoeven; Jessica A Belser; Robin Robinson; Margret Nathan; Gale Smith; D Craig Wright; Rick A Bright
Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
Vaccine 2007;25(21):4283-90.
2007: Rick A Bright; Donald M Carter; Shannon Daniluk; Franklin Toapanta Yanchapaxi; Attiya Ahmad; Victor Gavrilov; Mike Massare; Peter Pushko; Nutan Mytle; Thomas Rowe; Gale Smith; Ted M Ross
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Vaccine 2007;25(19):3871-8.
2005: Peter Pushko; Terrence M Tumpey; Fang Bu; John Knell; Robin Robinson; Gale Smith
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
Vaccine 2005;23(50):5751-9.
2004: William S Romoser; Leonard P Wasieloski; Peter Pushko; John P Kondig; Kriangkrai Lerdthusnee; Marco Neira; George V Ludwig
Evidence for arbovirus dissemination conduits from the mosquito (Diptera: Culicidae) midgut.
Journal of medical entomology 2004;41(3):467-75.
2003: Edward L Nelson; DaRue A Prieto; Terri G Alexander; Peter Pushko; Loreen A Lofts; Jonathan O Rayner; Kurt I Kamrud; Bolyn Fralish; Jonathan F Smith
Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model.
Breast cancer research and treatment 2003;82(3):169-83.
2002: Thomas W Geisbert; Peter Pushko; Kevin Anderson; Jonathan Smith; Kelly J Davis; Peter B Jahrling
Evaluation in nonhuman primates of vaccines against Ebola virus.
Emerging infectious diseases 2002;8(5):503-7.
2002: Paul Pumpens; Raimundas Razanskas; Peter Pushko; Regina Renhof; Indulis Gusars; Dace Skrastina; Velta Ose; Galina Borisova; Irina Sominskaya; Ivars Petrovskis; Juris Jansons; Kestutis Sasnauskas
Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
Intervirology 2002;45(1):24-32.
2001: John S Lee; Peter Pushko; Michael D Parker; M T Dertzbaugh; L A Smith; Jonathan F Smith
Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.
Infection and immunity 2001;69(9):5709-15.
2000: Peter Pushko; Mike Bray; George V Ludwig; M Parker; Alan L Schmaljohn; A Sanchez; Peter B Jahrling; Jonathan F Smith
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Vaccine 2000;19(1):142-53.
1998: Michael Hevey; diane negley; Peter Pushko; J Smith; Alan L Schmaljohn
Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
Virology 1998;251(1):28-37.
1997: Peter Pushko; M Parker; George V Ludwig; Nancy L Davis; R E Johnston; Jonathan F Smith
Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Virology 1997;239(2):389-401.